Lake Street analyst Frank Takkinen reiterated a Buy rating on Envoy Medical (COCH – Research Report) today and set a price target of $6.00. The company’s shares closed yesterday at $4.48.
Takkinen covers the Healthcare sector, focusing on stocks such as ClearPoint Neuro, Apyx Medical, and Silk Road Medical. According to TipRanks, Takkinen has an average return of 7.9% and a 41.95% success rate on recommended stocks.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Envoy Medical with a $6.00 average price target.
COCH market cap is currently $86.02M and has a P/E ratio of 156.58.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Envoy Medical (COCH) Company Description:
Anzu Special Acquisition Corp I is a blank check company.
Read More on COCH:
- Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 – 9, 2024
- Envoy Medical reports FY23 EPS ($2.38) vs ($1.57) last year
- Envoy Medicalto participates in a conference call hosted by Northland
- Envoy Medical to Participate in the 36th Annual ROTH Conference
- COCH Stock trading resumes
